Monoclonal antibody of 100 μg targeting Granulysin for FCM, ICC, IPP, WB
| Product Specifications | |
| Application | FC, ICC, IP, WB |
| Reactivity | Human |
| Clonality | Monoclonal IgG2a |
| Host | Mouse |
| Immunogen | Human full-length expression plasmid Guranyuraishin |
| Gene ID - Human | |
| Formulation | 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative iscontained. |
| Citations for Anti-Granulysin (Human) mAb (Clone: RF10) – 8 Found |
| Chung, Wen-Hung; Hung, Shuen-Iu; Yang, Jui-Yung; Su, Shih-Chi; Huang, Shien-Ping; Wei, Chun-Yu; Chin, See-Wen; Chiou, Chien-Chun; Chu, Sung-Chao; Ho, Hsin-Chun; Yang, Chih-Hsun; Lu, Chi-Fang; Wu, Jer-Yuarn; Liao, You-Di; Chen, Yuan-Tsong. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nature Medicine. 2008;14(12):1343-50. PubMed - Comments: Used in: WB |
| Merlo, Anna; Turrini, Riccardo; Bobisse, Sara; Zamarchi, Rita; Alaggio, Rita; Dolcetti, Riccardo; Mautner, Josef; Zanovello, Paola; Amadori, Alberto; Rosato, Antonio. Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors. Journal Of Immunology (Baltimore, Md. : 1950). 2010;184(10):5895-902. PubMed - Comments: Used in: FCM |
| Clayberger, Carol; Finn, Michael W; Wang, Tianhong; Saini, Reena; Wilson, Christine; Barr, Valarie A; Sabatino, Marianna; Castiello, Luciano; Stroncek, David; Krensky, Alan M. 15 kDa granulysin causes differentiation of monocytes to dendritic cells but lacks cytotoxic activity. Journal Of Immunology (Baltimore, Md. : 1950). 2012;188(12):6119-26. PubMed - Comments: Used in: ICC |
| Sekiguchi, Nodoka; Asano, Naoko; Ito, Toshiro; Momose, Kayoko; Momose, Masanobu; Ishida, Fumihiro. Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms. International Journal Of Hematology. 2012;96(4):461-8. PubMed - Comments: Used in: ICC |
| Wei, Hung-Mu; Lin, Li-Chih; Wang, Chiu-Feng; Lee, Yi-Jang; Chen, Yuan-Tsong; Liao, You-Di. Antimicrobial Properties of an Immunomodulator - 15 kDa Human Granulysin. Plos One. 11(6):e0156321. PubMed - Comments: Used in: ICC |
| Weinborn, Marie; Barbaud, Annick; Truchetet, Francois; Beurey, Philippe; Germain, Lucie; Cribier, Bernard. Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression. International Journal Of Dermatology. 2016;55(11):1225-1233. PubMed - Comments: Used in: IHC |
| Second, Julie; Velter, Charles; Calès, Sophie; Truchetet, François; Lipsker, Dan; Cribier, Bernard. Clinicopathologic analysis of atypical hand, foot, and mouth disease in adult patients. Journal Of The American Academy Of Dermatology. 2017;76(4):722-729. PubMed - Comments: Used in: IHC |
| Hsiao, Ya-Wen; Lai, Tsung-Ching; Lin, Yu-Hsiang; Su, Chia-Yi; Lee, Jih-Jong; Liao, Albert Taiching; Lin, Yuan-Feng; Hsieh, Shu-Chen; Wu, Alexander T H; Hsiao, Michael. Granulysin expressed in a humanized mouse model induces apoptotic cell death and suppresses tumorigenicity. Oncotarget. 2017;8(48):83495-83508. PubMed - Comments: Used in: WB |